ONCSQ vs. CLVR, EFTR, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, and BFRIW
Should you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.
OncoSec Medical vs. Its Competitors
OncoSec Medical (NASDAQ:ONCSQ) and Clever Leaves (NASDAQ:CLVR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, community ranking, analyst recommendations, risk, profitability and earnings.
OncoSec Medical has a beta of -19.7, meaning that its stock price is 2,070% less volatile than the S&P 500. Comparatively, Clever Leaves has a beta of 3516.09, meaning that its stock price is 351,509% more volatile than the S&P 500.
Clever Leaves received 13 more outperform votes than OncoSec Medical when rated by MarketBeat users.
6.9% of Clever Leaves shares are owned by institutional investors. 1.3% of OncoSec Medical shares are owned by company insiders. Comparatively, 8.2% of Clever Leaves shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Clever Leaves has higher revenue and earnings than OncoSec Medical.
In the previous week, OncoSec Medical had 1 more articles in the media than Clever Leaves. MarketBeat recorded 1 mentions for OncoSec Medical and 0 mentions for Clever Leaves. OncoSec Medical's average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.
Summary
Clever Leaves beats OncoSec Medical on 6 of the 7 factors compared between the two stocks.
Get OncoSec Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
ONCSQ vs. The Competition
OncoSec Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ONCSQ) was last updated on 6/15/2025 by MarketBeat.com Staff